Vimarsana
Biggest News Aggregation in the World

Page 2 - Pharma Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Services Today - Breaking & Trending Today

Indica Labs Announces AI-Powered HALO(R) Software Release for Digital Pathology Research in Life Sci - Vimarsana News

Indica Labs Announces AI-Powered HALO(R) Software Release for Digital Pathology Research in Life Sci

The 4.0 releases of HALO®, HALO AI, and HALO Link offer researchers and pathologists the latest advances in AI-powered tissue analysis. ALBUQUERQUE, NM / ACCESSWIRE / May 29, 2024 / Indica Labs, the global leader in AI-powered digital pathology solutions, announced today the release of the transformative new...

New Mountain Finance Corporation Announces Financial Results for the Quarter Ended March 31, 2024 - Vimarsana News

New Mountain Finance Corporation Announces Financial Results for the Quarter Ended March 31, 2024

Reports Net Investment Income of $0.36 per Share Declares a Regular Second Quarter Distribution of $0.32 per Share and a Supplemental Distribution of $0.02 per Share ...

[Event] Pharma and MedTech Services Investment Summit 2024 - May 2nd, San Francisco, CA | McDermott Will & Emery - Vimarsana News

[Event] Pharma and MedTech Services Investment Summit 2024 - May 2nd, San Francisco, CA | McDermott Will & Emery

YOUR SOURCE FOR SUCCESS IN PHARMA AND DEVICE SERVICES INVESTING - Join C-suite executives, senior private equity professionals, investment bankers and other industry...

Mubadala Investment Company: Mubadala plans big deals in India's healthcare space - Vimarsana News

Mubadala Investment Company: Mubadala plans big deals in India's healthcare space

Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a focus on pharmaceuticals, outsourced pharma services, and medtech, Mubadala aims to deploy capital meaningfully in India. This move aligns with Mubadala's strategy to generate sustainable financial returns. They have made significant investments globally and are now looking to expand their presence in India's healthcare landscape.

Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Advancements in Containment Technologies, and Increasing Investment for Manufacturing Units - Vimarsana News

Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Advancements in Containment Technologies, and Increasing Investment for Manufacturing Units

/PRNewswire/ -- The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End...